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Abstract
The mechanism(s) by which bacterial communities impact susceptibility to infectious dis-
eases, such as HIV, and maintain female genital tract (FGT) health are poorly understood.
Evaluation of FGT bacteria has predominantly been limited to studies of species abun-
dance, but not bacterial function. We therefore sought to examine the relationship of bacte-
rial community composition and function with mucosal epithelial barrier health in the context
of bacterial vaginosis (BV) using metaproteomic, metagenomic, and in vitro approaches.
We found highly diverse bacterial communities dominated by Gardnerella vaginalis associ-
ated with host epithelial barrier disruption and enhanced immune activation, and low diver-
sity communities dominated by Lactobacillus species that associated with lower Nugent
scores, reduced pH, and expression of host mucosal proteins important for maintaining epi-
thelial integrity. Importantly, proteomic signatures of disrupted epithelial integrity associated
withG. vaginalis-dominated communities in the absence of clinical BV diagnosis. Because
traditional clinical assessments did not capture this, it likely represents a larger underrepre-
sented phenomenon in populations with high prevalence ofG. vaginalis. We finally demon-
strated that soluble products derived fromG. vaginalis inhibited wound healing, while those
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derived from L. iners did not, providing insight into functional mechanisms by which FGT
bacterial communities affect epithelial barrier integrity.
Author Summary
The female genital tract (FGT) is a key mucosal surface in the context of HIV transmis-
sion. Lactobacillus species are beneficial to the FGT, while Garderella vaginalis and other
anaerobic bacteria are detrimental. Bacterial vaginosis (BV) is an inflammatory condition
characterized by an outgrowth of G. vaginalis and other anaerobes, which is linked to
increased HIV acquisition rates. However, the mechanism behind this remains unknown.
Here, we used a novel proteomic approach to simultaneously evaluate host and bacterial
functions in the FGT. We found that women with G. vaginalis-dominated FGT bacterial
communities always displayed markers of decreased epithelial barrier integrity, and
decreased wound healing capacity. We also demonstrated that the abundance of proteins
from G. vaginalis associated with these signatures of disrupted epithelial integrity. Finally,
we showed that products derived from G. vaginalis prevented healing of wounded cell
monolayers while products derived from L. inersmaintained the ability of the cell mono-
layers to close wounds. This study provides novel mechanistic insight into the link
between BV and increased HIV acquisition rates.
Introduction
Mucosal surfaces exposed to the external environment contain distinct bacterial communities
that exist in relationship with the host and can contribute to health and functioning. These bac-
terial communities have been linked to several human diseases and overall health [1], and can
vary between individuals, but also over time within the same person [2]. In the female genital
tract (FGT), colonization by Lactobacillus species and other lactate-producing bacteria helps to
inhibit colonization by pathogenic bacteria [3]. However, colonization by more diverse com-
munities of anaerobic bacteria, notably Gardnerella vaginalis, is common [4], and often associ-
ated with the development of bacterial vaginosis (BV) [5]. BV is highly prevalent, affecting
4–58% of women globally; some areas, such as sub-Saharan Africa have rates as high as 55%
[6]. BV is associated with significant health consequences, including pre-term birth, post-par-
tum endometriosis, pelvic inflammatory disease, upper reproductive tract infections, and
increased susceptibility to sexually transmitted infections (STI’s) [7, 8], with HIV being highly
significant [9, 10]. Indeed, a recent meta-analysis linked BV to a 60% increase in HIV acquisi-
tion rates [11]. However, while these relationships between microbial composition and vaginal
health have been described epidemiologically, there is limited understanding about the mecha-
nisms underlying the impact of bacterial dysbiosis on the vaginal mucosa.
Maintenance of the mucosal barrier is critical for preventing invading microorganisms,
including HIV, from penetrating into tissues and entering circulation [12]. Bacterial diversity
in the FGT has been strongly associated with negative consequences for FGT mucosa. Highly
diverse communities dominated by G. vaginalis and Prevotella are associated with upregulated
expression of Toll-like Receptor (TLR) and NFkB pathways, leading to increased pro-inflam-
matory cytokine concentrations and activation of immune cells [13]. While it is widely appreci-
ated that BV is associated with inflammation, the mechanism that elicits this inflammation or
the bacterial proteins associated with inflammation remain unresolved [14], which may partly
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explain the limited effectiveness of antimicrobial treatment for BV [15–17]. Bacterial metabo-
lites including hydrogen peroxide, antimicrobial peptides, and acids that reduce the FGT pH
have been proposed to have an important impact in sustaining mucosal health [3]. Further-
more, the integrity of mucosal epithelial surfaces has been shown to depend on bacterial com-
munity composition in other diseases [18], and has been proposed to be important in the FGT
during bacterial dysbiosis [19], but this has not been extensively studied. Each of these factors
likely impact disease susceptibility independently, and a Lactobacillus-dominant microbiota
likely contributes to many of these factors to maintain the function of the healthy FGT and
inhibit infections. Taken together these studies suggest that host-microbe interactions are key
to understanding negative consequences on vaginal health, yet this interaction remains poorly
defined in human cohorts [20].
We sought to better understand the relationship between mucosal health and bacterial diver-
sity using a combination of metaproteomics and metagenomics, which to our knowledge repre-
sents the first attempt at integrating these approaches to study the FGT. Indeed the functional
diversity of the bacterial proteome, and how this relates to FGT health and inflammation has
not been assessed comprehensively, and has largely been limited to 16S rRNA gene sequencing.
Thus, we hypothesized that bacterial protein factors can influence FGTmucosal health and
affect disease susceptibility. Here we characterized FGT bacterial communities in two distinct
human cohorts, longitudinally and cross-sectionally, in asymptomatic and symptomatic women
with BV, uncovering bacterial-host interactions leading to wound healing impairment.
Results
Vaginal bacterial proteome structure and diversity associate with
dysbiosis and clinical BV
Cervicovaginal secretion samples from two cohorts of women were evaluated to understand
the mucosal environment associated with bacterial dysbiosis. We first assessed mucosal
changes in women at BV+ or BV- time points (Cohort 1, n = 10), through a combination of
mass spectrometry (MS) and 16S rRNA gene sequencing. MS analysis identified 1123 unique
proteins, including 434 human and 689 bacterial proteins from 64 species. To assess the diver-
sity of the bacterial proteome, we quantified the relative proteome load of each bacterial genus
in each sample by summing the total number of protein spectral counts assigned to each genus,
an approach previously shown to directly correlate with colony-forming units [21]. We clus-
tered the bacterial proteomes from the twenty samples using unsupervised hierarchical cluster-
ing. Two major bacterial proteomes were identified, dominated by either Lactobacillus iners
(Group 1, or G1) or Gardnerella vaginalis (Group 2, or G2) (Fig 1A, species-level taxonomy
shown in S1A Fig), which were used for downstream comparisons. In G1, L. iners proteins
accounted for 87–100% of the total protein load while in G2, G. vaginalis proteins accounted
for 48–96%. Compared to those in G1, the bacterial proteomes in G2 displayed significantly
higher species diversity (S1C Fig). G2 profiles also had higher overall bacterial protein load
when normalized to the total protein content (0.34 log10, +2.2 fold higher; S1E Fig). L. iners
dominated the FGT bacterial proteome of eight of the 10 patients from Cohort 1 at the time
point without clinically diagnosed BV, but not the remaining two. Patient “10“, at the time
point without BV, displayed a high abundance of G. vaginalis with a lower abundance of L.
iners, and Patient “6”at the time point without BV had high levels of Lactococcus lactis and
Streptococcus mitis. In contrast, all samples taken during episodes of BV had high abundances
of proteins from G. vaginalis, Prevotella spp., Streptococcus mitis, Escherichia coli, and Atopo-
bium vaginae, which have been previously identified as part of BV-associated bacterial commu-
nities [7].
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Bacterial community composition for G1 and G2 was confirmed by 16S rRNA gene
sequencing (Fig 1B). According to 16S rRNA gene sequencing, G1 communities were domi-
nated by Lactobacillus spp. (26–99% of the total community), and G2 communities were domi-
nated by Gardnerella, but at lower proportions than were detected by MS (17–66% of the total
community). As with MS, bacterial genera detected in BV-positive individuals by 16S rRNA
gene sequencing included Sneathia, Prevotella, Atopobium,Megasphera, and others. 16S rRNA
gene sequencing also detected greater bacterial diversity in the G2 samples compared to G1
Fig 1. Mass spectrometry and 16S sequence analysis of cervicovaginal secretions show two distinct bacterial groups dominated by
Lactobacillus (G1) orGardnerella (G2) in two distinct cohorts. (A) Bacterial genera distributions detected in Cohort 1 using MS. Bacterial abundances
from the MS data were calculated by summing normalized total spectral counts for all proteins associated with a genus/species. Clustering of samples
was performed using unsupervised hierarchical linkage with average Euclidean distances of the proportional bacterial abundance in each sample. (B)
Bacterial genera distributions for Cohort 1 detected using 16S rRNA gene sequencing shows close concordance to MS, and clustered into two groups
based on Lactobacillus (G1) orGardnerella (G2) dominance. Bacterial genera detected in Cohort 2 using MS (C) showed similar grouping as Cohort 1.
Nugent scores (top) and bacterial alpha diversity (Shannon’s H index, bottom) are also shown.
doi:10.1371/journal.ppat.1005889.g001
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(S1C Fig). Several species detected by 16S and not by MS included Leptotrichia, Fastidiosipila,
Shuttleworthia, and Aerococcus. Overall, this demonstrates significant heterogeneity in the
structure of FGT bacterial communities between clinically defined BV and asymptomatic time
points, that G. vaginalis and other anaerobes associate with BV, and that specific species domi-
nate the bacterial proteome landscape in mucosal secretions.
Vaginal bacterial proteome variation evident in asymptomatic women
from an independent cohort
Mucosal samples from a separate group of 31 women from North America (Cohort 2) were
analyzed to further evaluate associations between FGT bacterial proteome diversity and BV.
MS analysis of Cohort 2 samples showed similar trends to that of Cohort 1 (Fig 1C, species-
level taxonomy shown in S1B Fig), including Lactobacillus spp.-dominant (G1) and G. vagina-
lis-dominant (G2) communities. A wider distribution of lactobacilli including L. iners, L. cris-
patus, and L. jensenii was observed in G1 in Cohort 2 than Cohort 1. Varying abundances of
other BV-associated bacteria including Prevotella spp., Atopobium vaginae,Mobiliuncus
mulieris, and Sneathia sp. were also observed. In Cohort 2, there was no difference in the spe-
cies diversity of G1 compared to G2 (S1D Fig). While all 7 women with BV clustered into G2,
46% of participants demonstrated a G. vaginalis-dominated proteome despite a lack of clinical
BV diagnosis, consistent with the observation that not all women have Lactobacillus-dominant
FGT microflora despite low Nugent scores. Also similar to Cohort 1, G2 in Cohort 2 had higher
overall microbial proteome burden than G1 (1.5-fold higher; S1F Fig), indicating further
changes in bacterial community function. This agrees with other studies showing Lactobacillus
dominance varies between 37–90% of women, with greater diversity and variation in African
women [5, 13, 22].
Vaginal metaproteome profiles are not associated with clinical variables
As bacterial diversity has been associated with other biological variables, such as concurrent
STI’s [23] and hormonal contraceptive usage [10], we compared clinical characteristics
between Lactobacillus and Gardnerella-dominant groups (Cohort 1-Table 1; Cohort 2-
Table 2). With the exception of BV status, we found no differences between G1 and G2 with
respect to age, contraceptive use, antimicrobial usage, last menstrual period, detectible STI’s, or
sexual practices in either cohort. There were differences in Amsel’s criteria collected from
Cohort 2 (S1 Table) between G1 and G2, where vaginal pH, clue and white blood cell presence
was higher in women with G2 bacterial proteome profiles, in agreement with clinical BV status.
Overall, there was no evidence to support that vaginal bacterial profiles were related to exoge-
nous hormonal contraceptive use, the menstrual cycle, sexual behaviors, or concurrent STI’s in
these cohorts.
Lactobacillus andGardnerella-dominated FGT bacterial communities
exhibit divergent functional traits
As the functional diversity of FGT-resident bacteria remained undefined we characterized the
major bacterial pathways present in G1 and G2 profiles (Fig 2). Major functional categories
represented in either group included transport and catabolism (G1 average 19.5%; G2 average
12.6%), carbohydrate metabolism (1 average 14.5%; G2 average 15.7%), as well as nucleotide
and amino acid metabolism (G1 average 2.6%/1.8%; G2 average 2.0%/1.4%).
However, unique functional signatures were observed between G1 and G2 FGT bacterial
communities. Across both cohorts, the G1 group showed significant enrichment of proteins
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involved in transport and catabolism (6.9% higher), energy metabolism (5.6% higher), and
folding, sorting, and degradation (4.9% higher), while G2 was highly significantly enriched in
membrane transport functions (22% higher). Twelve bacterial proteins were significantly dif-
ferentially abundant after multiple comparison correction between G1 and G2 in Cohort 1 (S2
Table). Proteins enriched in G1 mostly belonged to L. iners proteins and were involved in
homolactic fermentation of carbohydrates including glyceraldehyde-3-phosphate dehydroge-
nase (GAP-DH), pyruvate kinase (PK), and lactate dehydrogenase (LDH). Proteins enriched in
G2 were all G. vaginalis proteins and included a MalE-type ABC sugar transport system peri-
plasmic component (MAL-E ABC) and an alpha-1,4 glucan phosphorylase, an enzyme that
degrades starch and glycogen, suggesting that G. vaginalis directs its metabolism towards liber-
ation and uptake of extracellular saccharides. Although many of these proteins were also differ-
entially abundant between G1 and G2 in Cohort 2 they did not pass multiple comparison
correction. Overall this shows that ‘core’ functional pathways necessary to host-associated
Table 1. Clinical characteristics of participants in Cohort 1 (Kenya).
Variable All sample time points G1 G2 P value
Age (avg) 37.8 37.7 37.8 0.96
Nugent score positive 11/20 1 10 <0.0001
Antimicrobial usage (Metronidazole) 0% 0% 0% 1.00
Actively cycling (%) 100% 100% 100% 1.00
Days since LMP if cycling (median) 12.5 (+/- 12.6) 14.5 (+/- 10) 11.5 (+/-4.8) 0.14
Contraceptive use NoHCU (6/10, 60%), AnyHCU (3/10,
30%), Switched CU (1/10, 10%)
NoHCU (6/9, 67%), AnyHCU (3/
9, 33%)
NoHCU (5/9, 56%),
AnyHCU (4/9, 44%)
0.50
Any other STI (proportion) 3/20 (15%) 1/10, 1 Trichomonas, (same
person both timepoints)
2/10, 1 Trichomonas, 1
Chlamydia
0.50
Number of sex acts w/partner 8.5 8.5 +/- 6.4 10 +/- 7.1 0.49
# condom sex acts w/ partner
(median)
2 +/- 3.8 2 +/- 3.7 2 +/- 4.1 1.00
# unprotected condomless sex acts
with partner (median)
3.5 +/- 5.9 3 +/- 6.9 4 +/- 5.4 0.48
HCU: hormonal contraceptive user
doi:10.1371/journal.ppat.1005889.t001
Table 2. Clinical characteristics of participants in Cohort 2 (North America).
Variable G1 G2 P value
Age (avg.) 26.6 32 0.15
Nugent Score positive (7–10) 0/13 7/18 0.01
Antibiotic use reported 0% 0% 1.00
Actively cycling (%) 100% 100% 1.00
Days since LMP if cycling
(median)
13 18 0.12
Contraceptive use 0 0 1.00
Any other STI (proportion) 0 0 1.00
Douching 0 0 1.00
Sex w/in last 24 hrs (%) 1/13 (7.7%) 2/18 (10.5)% 0.62
Condom usage (%) Sometimes (6/13, 46%), Always (1/13, 7.7%), Blank
(5/13, 38%)
Sometimes (16/18, 89%), Always (1/18, 5.6%), Blank
(1/18, 5.6%)
0.46
Ethnicity Black/non-hispanic (9), Asian (1), Hispanic (0),
Caucasian (3)
Black/non-hispanic (15), Asian (1), Hispanic (1),
Caucasian (0)
0.02
doi:10.1371/journal.ppat.1005889.t002
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bacterial life within the FGT include carbohydrate, amino acid, and translational machinery,
while perturbations to membrane transport and carbohydrate catabolism are likely important
for pathogenic states.
Vaginal epithelial wounding and immune activation associates with
bacterial communities despite absence of clinical symptoms
Bacterial dysbiosis impacts HIV acquisition risk [10, 11, 24], reproductive health [7], and muco-
sal cellular activation [13], but the effect on the FGT is not well defined. Our analysis revealed
that 69/434 (15.8%, 15 passing 5% FDR) and 64/434 (14.7%, 19 passing 5% FDR) host proteins
were significantly differentially abundant between G1 and G2 profiles in Cohort 1 and 2, respec-
tively. For Cohort 2, comparison based on bacterial groups rather than Nugent score criteria
yielded greater host proteome differences, statistically (9.2% vs. 15.8%, P<0.05), and in
Fig 2. Cervicovaginal bacterial profiles display diverging functional traits. Bacterial proteome functions for both cohorts were
determined by KEGG ontology. For both cohorts, G1 profiles (Lactobacillus dominant) showed increased abundance of proteins related
to Transport and Catabolism and Energy Metabolism while G2 (Gardnerella dominant) showed increased abundances of proteins
associated with Membrane Transport. Student’s t-tests were used to compare the abundances of each category between G1 and G2.
doi:10.1371/journal.ppat.1005889.g002
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magnitude (5 vs. 6 Log2 Fold Change; S1G/S1H Fig), suggesting that bacterial community com-
position, rather than clinical BV criteria, more accurately classifies mucosal inflammation. This
comparison was not possible for Cohort 1, as all G2 profiles had clinically defined BV. Hierarchi-
cal cluster analysis revealed that longitudinal changes from G1 to G2 profiles in Cohort 1 were
clearly distinguishable by two major branches of host proteins (S2A/S2B Fig). Proteins more
abundant in G1 (Branch 1) associated with epidermis development and the cornified envelope,
whereas G2 (Branch 2) showed increased factors involved in cytoskeletal-binding, threonine pro-
teases involved in proteasome activity, as well as vesicular components and the melanosome.
Many of these included S100 proteins and innate immune factors, important for antimicrobial
defense based on gene ontology (DMBT1, CADH1, S10A7, EFHD2, S10AB, S10A6, TGM3,
K2C1 S10A2). Similarly, in Cohort 2, hierarchical cluster analysis showed that proteins more
abundant in G1 (Branch 1) associated with epidermis development, structural molecular activity,
and the cornified envelope, while proteins elevated in G2 (Branch 2) also included ectoderm
development and differentiation, although were related to cytoskeletal activity (S2C/S2D Fig).
Many of these are important for leukocyte-mediated immunity and wounding responses based
on their gene ontology (A1AT, IC1, GELS, CO3, PEBP1, PRDX1, PRDX2, CO4A, ANXA8).
Seventeen proteins were differentially abundant across both cohorts (Fig 3A). Host proteins
more abundant in G2 profiles included apoptotic regulators (PRDX, NDKB, CADH1) and leu-
kocyte migration factors (PLST), while G1 profiles showed increased keratinization, epidermis
development, and cornified envelope (INVO, SPR1A) factors (Fig 3B). Of particular interest,
the abundances of INVO and SPR1A were 14.7 and 7.2-fold lower in women G2 microbial pro-
files Cohorts 1 and 2, respectively. In Cohort 2, INVO and SPR1A were lower for women with
G2 microbial profiles even if they had not been clinically diagnosed for BV (Fig 3C). These pro-
teins are known to act as scaffolding for epidermal layers and are important for proper barrier
function [25], and immunohistochemical analysis confirmed the presence of INVO and
SPR1A in cervical and vaginal tissues, where they strongly associated with the squamous epi-
thelium and stratum corneum in healthy FGT tissue (S3 Fig). Collectively these data show an
association of heightened immune activation, apoptosis, and decreased epithelial barrier func-
tion in women with G. vaginalis-dominated bacterial profiles and that these effects are evident
in G. vaginalis-dominated communities in the absence of clinical diagnosis.
Functional variation in the vaginal microbiome correlates with epithelial
wounding
Due to the strong association of epithelial development pathways with different bacterial
groups, we compared cornified envelope factors INVO and SPR1A to bacterial proteins. Nine-
teen bacterial proteins had strong associations in at least one comparison against either INVO
or SPR1A after correcting for multiple comparisons. Proteins from L. iners that positively cor-
related with INVO and SPR1A were involved in Catabolism and Energy Metabolism pathways,
including glycolysis and homolactic fermentation of sugars (Embden-Meyerhoff-Parnas
(EMP) pathway) (Fig 4A/4B). These included a putative fructose 1,6-bisphosphate aldolase
(PFBA), PK, GAP-DH, and LDH, as well as a ferritin-like protein (FLP), which is important
for sequestering excess iron and preventing oxidative damage [26]. Bacterial proteins that neg-
atively correlated with INVO and SPR1A belonged to alternate sugar metabolism pathways
(phosphoketolase pathway), transport functions, and amino acid catabolism. The majority of
these belonged to G. vaginalis (Fig 4C/4D), including D-xylulose 5-phosphate/D-fructose
6-phosphate phosphoketolase (XFBP), a putative sugar-binding secreted protein (P-SBSP),
MAL-E ABC, an extracellular solute binding protein (ESBP), and glycine oxidase (GOx). A
membrane protein from Prevotella sp., sharing sequence homology with SusD-like (starch-
Microbiome Composition and Function in the Female Genital Tract
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binding) protein, was also negatively associated (S4 Fig). Many associations with vaginal pH
were also observed, including negative associations with enzymes from L. iners (PK, LDH,
elongation factor tu, and FLP) (S5A Fig), and positive associations with enzymes from G. vagi-
nalis, including GOx, which catalyzes the conversion of glycine into glyoxalate, ammonia, and
hydrogen peroxide (S5B Fig). Therefore a clear relationship between metabolic function, epi-
thelial barrier protein levels, and vaginal pH was observed, demonstrating that these microbial
pathways may be an important component of mucosal barrier disruption and vaginal health.
Soluble products derived from culture ofG. vaginalis impair wound-
healing capacity.
The association of bacterial communities with barrier integrity proteins led us to hypothesize
that wound-healing capacity may be supported or inhibited by specific bacterial species and/or
their products. We thus performed a classical wound-healing assay wherein we cultivated rele-
vant cervical cell line (HeLa CCL-2) in the presence of supernatants derived from cultures of L.
Fig 3. Vaginal epithelial barrier proteins vary significantly betweenmicrobial groups and are considerably lower inGardnerella (G2) vs.
Lactobacillus (G1) dominant profiles. (A) Heatmap of differentially abundant host proteins found in common between Cohort 1 (longitudinal) and
Cohort 2 (cross-sectional) based on cervicovaginal microbiome profiles. (B) Functional annotation of differentially expressed proteins based on their gene
ontology. Fisher’s exact test was used to compare annotated protein functions between G1 and G2 across both cohorts. (C) Lowered cornified envelope
proteins (Involucrin and Small Proline-Rich Protein 1A) strongly correlate withG. vaginalis (G2) profiles, regardless of the presentation of clinical BV
symptoms for both cohorts. Student’s t-test was used to compare the abundances of INVO and SPR1A between G1 and G2. BP: Biological process; CC:
Cellular component.
doi:10.1371/journal.ppat.1005889.g003
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iners or G. vaginalis. Prior to adding culture supernatants, a wound was induced by scratching
HeLa cell monolayers. Incubation of scratched monolayers with L. iners culture supernatant
did not alter wound healing compared to the control incubations. However, incubation with G.
vaginalis culture supernatants significantly reduced wound healing after 24 hours compared to
both the control and L. iners conditions (Fig 5). These results confirm a relationship between
soluble compounds produced by the major bacterial species of the G1 and G2 profiles and
wound healing capacity. This implicates these species as important components or drivers of
epithelial barrier repair, maintenance, and disruption in the FGT.
Fig 4. Bacterial proteins significantly correlate with vaginal epithelial barrier markers. Spearman correlations between (A) Lactobacillus
proteins vs. INVO (B) Lactobacillus proteins vs. SPR1A; (C)G. vaginalis proteins vs. INVO; (D)G. vaginalis proteins vs. SPR1A. (SPR1A:
Small proline-rich protein 1A; INVO, Involucrin) for both cohorts. Only proteins that passed multiple comparison correction testing in at least one
comparison are shown (Bonferonni, P < 0.0003).
doi:10.1371/journal.ppat.1005889.g004
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Discussion
In this study, we demonstrated a novel metaproteomic approach to simultaneously assess
bacterial diversity, abundance, and function, along with host barrier and inflammation pro-
cesses, providing mechanistic insight relevant to women’s health. We described distinct vagi-
nal bacterial proteome profiles that were dominated by Lactobacillus spp. (G1) or G.
vaginalis (G2), where the latter associated with BV, increased community diversity, and sig-
nificant divergence from normal metabolic function. We next demonstrated that bacterial
functional profiles were significantly associated with cornified envelope factors in the FGT,
and this was affected even in the absence of clinical diagnosis. Finally, we found that predom-
inant species identified in this study, specifically G. vaginalis and L. iners, generate soluble
products that disrupt or maintain the ability of cervical epithelial cells to repair and close
wounds. Therefore, impaired wound healing is a potential mechanism by which key bacterial
species may impact mucosal barrier function and therefore disease and/or HIV/STI infection
risk. The association of vaginal inflammation and inflammatory vaginal bacteria with HIV
susceptibility indicates that targeting this mechanism may lead to novel prevention strategies
for HIV.
While increased diversity of bacterial communities has been linked to better mucosal func-
tioning in the gut [27, 28], low-diversity bacterial communities are beneficial for the FGT [5],
where increased diversity is strongly associated with BV [7]. Consistent with previous observa-
tions [5], many of the women in Cohort 2 with G. vaginalis-dominated communities were
asymptomatic for BV (61%), further supporting the fact that Nugent score is underestimating
the extent of non-Lactobacillus dominant communities. However, the effects on host epithelial
pathways, including decreased integrity and increased inflammatory pathways were still evi-
dent in the absence of clinical diagnosis. Lactobacillus spp. and G. vaginalis proteins comprised
Fig 5. G. vaginalis-derived soluble products inhibit wound healing of cervical cell monolayers. (A) Representative
light micrographs show that scratches in HeLa cell monolayers healed fully in the presence of NYCIII medium and L. iners,
culture supernatants while HeLa cell monolayers exposed toG. vaginalis culture supernatants did not heal fully or
expanded. (B) Statistical analysis of replicate co-culture experiments. Statistical significance was calculated using
ANOVA with Bonferonni correction. ***P<0.001.
doi:10.1371/journal.ppat.1005889.g005
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more of the soluble proteome load than might be inferred from 16S rRNA gene sequencing,
suggesting that these bacteria dominate the metabolic landscape of the FGT.
Metagenomic studies of the human microbiome have shown that core metabolic function is
less variable than the community composition [2]. In agreement with this, we observed that
the majority of assigned protein functions did not vary significantly, which likely represent
core metabolic functions. However, some functions varied between G1 and G2, including
increased carbohydrate metabolism, energy production, and folding/sorting functions in G1 to
enhanced membrane transport and secretion of extracellular products in G2, with L. iners and
G. vaginalis dominating these key functions. The increased abundances of enzymes important
for sugar transport and starch and glycogen catabolism in G2 suggest that G. vaginalismay out-
compete Lactobacillus spp. for the uptake of carbohydrate substrates. This agrees with a recent
study showing that women with BV have significant metabolite alterations in cervicovaginal
mucous, including lower levels of carbohydrates, amino acids, and lactate, accompanied by
increased levels of amino acid catabolites and polyamines [29]. Overall, this demonstrates that
increased bacterial diversity is associated with changes in key metabolic pathways, which allows
for better understanding of dysbiosis in the FGT.
We found that G1 profiles from both cohorts strongly associated with cornified envelope
factors, especially INVO and SPR1A, which are expressed in the upper layers of the vaginal
and cervical epithelia, and aid in maintaining epithelial integrity. Our group has previously
reported that increased levels of cervocovaginal CD4+ T cells associated with lower levels of
cornified envelope factors [30], demonstrating the important link between vaginal epithelial
integrity and HIV acquisition risk. G1 profiles were also associated with higher levels of anti-
microbial peptides, such as dermcidin, which is important for host defense against microor-
ganisms [31]. In comparison, the G2 bacterial profiles correlated with lower cornified
envelope and epithelial barrier factors, increased cytoskeletal elements important for cell
migration, and increased proteasome factors. This agrees with other studies showing that BV
associates with activation of innate immune and inflammation pathways in the FGT, includ-
ing increased complement [32], proteasome levels [33], and pro-inflammatory cytokines and
activated CD4+ T-cells [13]. Importantly, G2 bacterial proteome profiles associated with
decreased abundances of INVO and SPR1A regardless of clinical BV status. This finding dem-
onstrates that current methods used to diagnose BV likely underestimate the true extent of
bacterial dysbiosis on mucosal barrier function the FGT, as the Nugent Scores were poor pre-
dictors of BV, especially for Cohort 2. Thus, new methods to detect and treat G. vaginalis in
the FGT could aid in reducing HIV acquisition risk by promoting mucosal and epithelial bar-
rier integrity, and reduced inflammation.
Catabolic enzymes involved in homolactic fermentation of glucose from Lactobacillus,
such as L-lactate dehydrogenase, correlated with higher epithelial barrier proteins, while
membrane transporters, extracellular proteins, and alternate routes of carbohydrate metabo-
lism (heterolactic fermentative or phosphoketolase pathways) from G. vaginalis were nega-
tively correlated. In addition, GOx, was strongly correlated with increased vaginal pH,
implicating a role of this enzyme in altered vaginal pH during dysbiosis. To our knowledge
this is the first time these bacterial enzymes have been associated with epithelial disruption
signatures and vaginal pH. Collectively, this shows a relationship between bacterial commu-
nity structure, metabolic function, disruption of epithelial proteins important for barrier
integrity, and overall vaginal health.
We also demonstrated that G. vaginalis culture supernatants inhibited healing of scratched
HeLa cell monolayers while, L. iners culture supernatants maintained effective wound healing.
Based on these data, G. vaginalis is likely an important component or a potential driver of sub-
verting the wound healing process. While acknowledging that HeLa cell monolayers do not
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completely recapitulate the squamous epithelium or immune environment of the FGT, this
nevertheless supports would healing as an underlying mechanism. Taken collectively, and con-
sidering the metaproteomic, metagenomic, and in vitromodels, these data suggest that G. vagi-
nalis releases a variety of extracellular products in the vaginal compartment that aid in uptake
for nutrients, alter the vaginal microenvironment, contribute to innate immune activation, and
prevent healing of the epithelial barrier. Future studies to identify exact protein pathways
involved, how they may be altered, and more advance animal and engineered tissue models
would help better decipher these host-microbiome interactions.
It is important to compare discuss the benefits and limitations of metaproteomics com-
pared to 16S rRNA-based techniques to characterize microbial communities in the vaginal
compartment. Both techniques are quantitative and spectral counts by MS have been shown
to correlate directly to colony-forming units [21]. An advantage of 16S over MS is greater res-
olution of the overall community structure, and while we showed high sensitivity to identify
species that were at 0.1% of the population by MS, 16S captured more overall bacterial spe-
cies. It is likely that the larger dynamic range of the proteome over the genome is a large con-
tributing factor to this observation. Both 16S and MS rely on curated databases to identify
species and are subjected to this same limitation in availability and extensiveness of libraries.
While databases for 16S rRNA genes are likely more comprehensive, proteomic libraries are
growing and becoming more available. MS is advantageous in that it can provide direct spe-
cies-level identification, which is not achievable through high-throughput 16S rRNA gene
sequencing methods. Furthermore, metaproteomic analysis reveals bacterial functional and
metabolic activity, which is not provided by 16S-based approaches. Prior studies have
attempted to alleviate this using MS to correlate metabolite abundances with species abun-
dances [34], through metagenomic studies [35], or by employing computational methods to
estimate bacterial community functional capacity based on 16S rRNA gene signatures [36],
but nevertheless represent indirect methods to evaluate bacterial community functionality.
While 16S rRNA gene sequencing is a popular and well-validated method for studying micro-
bial communities, the use of metaproteomic approaches provides complimentary and invalu-
able data on community structure, function, and host inflammation to better study host-
bacterial relationships.
Our data provide novel mechanistic insight of how dysbiosis of vaginal bacterial communi-
ties may directly increase host susceptibility to infection through the disruption of epithelial
barriers, inhibition of wound repair, and induction of inflammation. In the context of HIV
transmission, inhibition of wound repair is under studied and may represent underlying mech-
anisms in other risk factors for HIV, including hormonal contraceptive usage, intravaginal
practices, and other STI’s. These pathways may also impact the effectiveness or responsiveness
to mucosa-targeted prevention technologies for other infections, such as microbicides or vac-
cines for HIV. In summary, this study delineated functional configurations of microbial com-
munities that impact vaginal health during BV, providing new information on host-bacterial
interactions, enabling future experiments to probe host-microbe relationships in the FGT that
could have important implications for women’s health.
Materials and Methods
Ethics statement
All women who participated in this study provided written informed consent. The studies were
approved by the University of Washington Human Subjects Review Committee, the Kenya
Medical Research Institute (KEMRI), Human Subjects Committee of the University of Illinois
at Chicago, and the Research Ethics Board of the University of Manitoba.
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Study cohorts
Study cohort 1 (Kenya). This study included longitudinal samples and data collected
from Kenyan female partners from HIV-1 serodiscordant couples enrolled in the Partners
PrEP study[37]. HIV-1 seronegative partners were followed at monthly visits that included
detailed assessments of behavioral and medical histories. For this study, we identified archived
cervical swab samples from 10 women in the placebo arm of the Partners PrEP study collected
at 2 time points: one at a visit where the participant tested positive for BV (Nugent’s score
7–10) and one at a visit where the participant tested negative for BV (Nugent’s score 0–3).
Exclusion criteria included those who exhibited genital ulcer disease through self-report or on
physical exam at the sample collection visit. All women remained HIV-1 negative throughout
the study. Women were also evaluated at baseline for bacterial STIs, Trichomonas vaginitis,
Neisseria gonorrhoeae, and Chlamydia trachomatis and treated if found to be positive.
Study cohort 2 (North America). A total of 31 women were included from this study site
from the University of Illinois as part of the UIC Project Wish cohort recruited for HIV preven-
tion studies. Participants were between the ages of 18 to 47, were not on any form of hormonal
contraception, and abstained from sexual intercourse, vaginal medication/creams, or douching
for at least 24 hours prior to sample collection. Ethnicity was predominantly Black/non-Hispanic
(n = 27), with few Caucasian (n = 3), Asian (n = 2), and Hispanic women (n = 1). All participants
underwent testing for HIV, Trichomonas vaginitis,Neisseria gonorrhoeae, and Chlamydia tracho-
matis from vagina swabs taken at the time of collection and were excluded if positive.
Cervicovaginal sample collection
Study cohort 1. Copan Floqswabs (Copan Diagnostics, Murrieta CA, USA) were used to
collect vaginal samples and samples were stored frozen at -80°C until analysis. The median
number of days between vaginal swab sample collection was 334 +/- 501 days.
Study cohort 2. Cervicovaginal lavage (CVL) samples were obtained by instilling 10 ml of
saline solution over the surface of the vaginal vault and ectocervix. The saline lavage was then
redrawn (8–10mL) using the same syringe with which it was instilled. All samples were imme-
diately stored on wet ice and subsequently frozen at -80°C within 1 hour of sample collection.
Bacterial vaginosis criteria. Cervicovaginal samples were utilized for identification of BV
using Nugent’s score criteria. Briefly, Gram-stained smears were assessed for absence of Lacto-
bacillus (scored 0–4), presence of Gardnerella and Bacteroidesmorphotypes (0–4), and pres-
ence of curved gram-variable rods (0–2) for a total score of 0–10 wherein 0–3 is healthy, 4–6 is
intermediate, and 7–10 is diagnostic for BV. For Cohort 2, Amsel criteria were also collected
including vaginal pH, clue cells on wet mount, and positive whiff test, and incorporated for a
positive classification for BV (any 3 of the 4 criteria).
Sample preparation for mass spectrometry
Vaginal swabs were eluted with 2 x 250ul washes in PBS (pH 7.0). Swab eluates (Cohort 1) or
CVL samples (Cohort 2) were then centrifuged in SpinX tubes with a bonded fritted bottom
(Corning, Corning, NY), and protein content determined by BCA assay (Novagen, Bilerica,
MA). Proteins were then denatured, reduced, alkylated, digested into peptides, and prepared
for mass spectrometry as described previously [38]. Detailed methods for this process are avail-
able in S1 Methods.
Mass spectrometry analysis
Briefly, peptide samples were injected into a nano-flow LC system (Easy nLC, Thermo
Fisher) connected inline to a LTQ Orbitrap Velos (Thermo Fisher) mass spectrometer, and
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analyzed in a label-free manner as described previously [38]. Peptide identity searching was
performed with Mascot v2.4.0 (Matrix Science) against a manually curated database com-
prised of the SwissProt Human & Bacteria (June 2015) and UniProtKB/Trembl All Bacteria
databases (August 2015). A decoy database was included to determine the rate of false discov-
ery. Protein identifications were confirmed using Scaffold (v 4.4.1, Proteome Software) with
confidence thresholds set at 95% protein identification confidence, requiring at least 2 unique
peptides and 80% peptide identification confidence. A combination of label-free methods
was used for protein quantitation: spectral counting (for microbial proteins and bacterial
diversity clustering, see below) and area-under-the-curve quantitation (Progenesis LC-MS
software (v4.0, Nonlinear Dynamics)). Criteria for assigning presence of microbial proteins
included those that had at least 1 peptide in one sample, and at least 2 peptides per protein
across all samples. These parameters resulted in a false discovery rate below 3.1% based on
the search results run against Mascot’s generated decoy database. For the latter, only proteins
that had an average co-variance of<25% (575 proteins), as determined through measure-
ments of standard reference sample run at 10 sample intervals (total 7 times), were utilized in
downstream analysis to exclude proteins with higher technical measurement variability.
Complete details of liquid chromatography and mass spectrometry instrument settings are as
described previously [38].
Proteomic data analysis
Human proteome. Protein relative abundance values were obtained by dividing by aver-
age intensity across all samples, followed by log transformation (base 2). Graphical representa-
tions of proteomic data were generated in R. Differentially abundant proteins were clustered
using unsupervised average linkage and Pearson correlation coefficient as the distance metric.
A complete list of host proteins detected in this study is available in S1 Data Set.
Microbial proteome. Microbial abundance was calculated by summing normalized total
spectral counts for all proteins associated with a genus/species. Unsupervised hierarchical
linkage with average Euclidean distances was performed in MATLAB using the proportional
microbial abundance in each sample, and stacked bar charts generated in R. K number
annotations were assigned using GhostKOALA to obtain KEGG category information29.
KEGG ontology (KO) assignments were manually curated to remove 7 categories associated
with organism-level functions and 1 general “Overview” category. All proteins associated
with these 8 categories were associated with had at least one other category. The average
number of KO categories with which each unique protein associated was 1.97 with a maxi-
mum of 7. Cumulative functional abundance for each category was calculated by summing
abundances of all associated proteins, and proteins belonging to multiple categories contrib-
uted to each of those associated. A complete list of bacterial proteins detected in this study is
available in S2 Data Set, and spectral counts for bacterial proteins are available in S3 Data
Set.
DNA extraction and 16S rRNA gene sequencing. Total genomic DNA from eluted swab
(Cohort 1) or CVL (Cohort 2) samples was extracted using the DNeasy Blood and Tissue Kit
(Qiagen, Valencia, CA) with modifications to enhance lysis, as previously described [39]. The
Microbiome Analysis Laboratory at Arizona State University performed V3–V4 region 16S
rRNA gene sequencing using the Illumina MiSeq sequencing platform, and sequences were
analyzed using the QIIME software package [40]. Complete details for DNA extraction and
sequence analysis are available in S1 Methods. All sequence data has been deposited to the
NCBI SRA under BioProject Accession Number PRJNA317390.
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Pathway and biofunctional analysis
Biological/molecular functions and cellular components were annotated based on gene ontolo-
gies using the DAVID Bioinformatics Resource (v6.7) [41], which calculates a modified Fish-
er’s Exact P value to determine the probability that the association between each protein in the
dataset and functional pathway is random. Functional categories were considered to be those
with P-values< 0.05 (Benjamini Hochberg adjusted) and at least 3 proteins selected to be posi-
tive associations.
Cell lines, bacterial strains, and culture conditions
HeLa (ATCC CCL-2) cells were obtained as a gift from the laboratory of Dr. Shiu-Lok Hu
(University of Washington), and were maintained in Dulbecco’s Modified Eagle’s Medium
(DMEM) supplemented with 4.5 g/L glucose, L-glutamine, 10% (v/v) fetal bovine serum
(Corning), and 1% (v/v) penicillin/streptomycin/amphotericin B solution (Gibco). HeLa cells
were incubated at 37°C with air/5% CO2 atmosphere. Gardnerella vaginalis ATCC 14018 and
Lactobacillus iners ATCC 55195 were obtained from the American Type Culture Collection,
and were maintained using HBT-Bilayer medium (BD) and NYCIII liquid medium with incu-
bation at 37°C with air/5% CO2 atmosphere. Frozen stocks were stored in 20% (v/v) glycerol at
-80°C.
Wound-healing assay
To assess the impact of different bacteria on the ability of cervical epithelial cells to repair
wounds, we utilized the well-established in vitro scratch assay [42]. To prepare live bacteria
and culture supernatants for the wound-healing assay, overnight cultures of L. iners and G.
vaginalis in NYCIII medium were grown as described above. Wells of a 24-well tissue culture
plate (Corning) were initially seeded with 50,000 HeLa cells in a volume of 500 μL DMEM and
incubated at 37°C under 5% CO2 until a confluent cell monolayer had formed. Monolayers in
each well were then scratched using a sterile P200 pipette tip. Live bacteria, bacterial culture
supernatants, or control solutions were then added to the wells. Images at five reference points
per well were captured using a Nikon Eclipse TS100 microscope equipped with a Nikon
DS-Ri1 camera and the size of the scratch at each reference point was manually analyzed using
the ImageJ software. The size of the wound was determined immediately after beginning (t = 0)
the experiment and then again after 24 hours (t = 24) of incubation at 37°C with air/5% CO2
atmosphere. Additional information on wound-healing assays is available in S1 Methods.
Statistical analysis. Independent (Mann-Whitney U-test) or paired sample t-tests were
used on normalized proteomic data for statistical comparisons. Unless otherwise noted, signifi-
cant changes were defined as those with a P-value below 0.05 after adjusting to a local false dis-
covery rate and multiple comparisons [43]. Chi-squared tests were used for categorical
variables. For the wound healing assay, the difference between the size of the scratch at t = 0
and t = 24 at each reference point was calculated and normalized to the initial scratch size to
determine the percent of the wound that had healed after 24 hours. ANOVA with Bonferroni
correction was conducted in GraphPad Prism (GraphPad).
Supporting Information
S1 Fig. Vaginal bacterial species diversity, protein abundance, and relationship to host pro-
tein expression as detected by mass spectrometry. (A) Bacterial species and proteome diver-
sity for Cohort 1. Most of the G1 communities were dominated by L. iners, while G. vaginalis,
P. amnii,Megasphaera sp., and others dominated the G2 communities. (B) Bacterial species
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and proteome diversity for Cohort 2. G1 communities were dominated by either L. iners, L.
crispatus, but also had the presence of L. gasseri, and L. jensenii. G2 communities were heavily
dominated by G. vaginalis. (C) Shannon Diversity detected for Cohort 1. The G2 group always
had higher diversity than the G1 group. (D) Shannon Diversity detected for Cohort 2. There
was no difference in the diversity between the G1 and G2 groups. (E/F) Total bacterial prote-
ome abudance differences between women with either a G. vaginalis or L. iners bacterial prote-
ome profile for Cohort 1 (E) and Cohort 2 (F). These graphs show bacterial protein levels (y
axis) as a function of abundance rank (x axis) in decreasing order. Median levels are shown
(log10), and student t-tests (Cohort 1: paired t test, parametric; Cohort 2: unpaired t test,
parametric) were used to determine statistical differences. G. vaginalis-dominant profiles
always had increased protein load compared to those dominated by Lactobacillus. (G/H) Vol-
cano plots depicting host protein expression differences using clinical BV status (G) or bacte-
rial community profile (H). The Y-axis of the volcano plot denotes statistical significance, and
the x-axis the fold-change (FC). Comparison of G1 and G2 community profiles, rather than
BV criteria, yielded more statistically relevant differences between the host proteome.
(TIF)
S2 Fig. Vaginal mucosal inflammation pathways of women from Cohort 1 and Cohort 2
associated with bacterial community composition.Heatmaps of differentially abundant host
proteins (P<0.05) in cervicovaginal secretions of women based on vaginal bacterial communi-
ties. (A) Differentially abundant host proteins for Cohort 1; (B) Functional annotation of dif-
ferentially expressed proteins based on their gene ontology for Cohort 1. (C)Heatmap of
differentially abundant host proteins for Cohort 2; (D) Functional annotation of differentially
expressed proteins based on their gene ontology for Cohort 2. BP: Biological process; CC: Cel-
lular component; MF: Molecular function.
(TIF)
S3 Fig. Immunohistochemical images of epithelial barrier proteins involucrin and small
proline-rich protein 1A in the vagina and cervix. Immunohistochemical analysis of cervical
and vaginal tissue revealed prominent expression of INVO and SPR1A in top layers of the
squamous epithelium in cervix and vagina, with both showing association with the cytoplasm
and nucleus membrane. Protein was not detected in glandular cells in cervix/endocervix.
(TIF)
S4 Fig. Membrane protein from Prevotella sp. that significantly negatively correlated with
the abundances of INVO (left) and SPR1A (right) for both cohorts.
(TIFF)
S5 Fig. Bacterial proteins that significantly correlate with pH in the cervicovaginal epithe-
lium. Four L. iners proteins negatively correlated with pH, including lactate dehydrogenase
(LDH) (A), and three G. vaginalis proteins positively correlated with pH, including glycine oxi-
dase (GOx) (B).
(TIFF)
S1 Table. Amsel criteria for Cohort 2 (North America).
(DOCX)
S2 Table. Proteins determined to be significantly differentially abundant between G1 and
G2 in Cohort 1 (BH P: Bejamani-Hochberg corrected P value; P<0.001).
(DOCX)
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S1 Methods. Containing information on mass spectrometry, DNA extraction and 16S
rRNA gene sequencing, and wound-healing assay.
(DOCX)
S1 Data Set. Human proteins detected by mass spectrometry (are under curve integration
(Progenesis)).
(XLSX)
S2 Data Set. Bacterial proteins detected by mass spectrometry (area under curve integra-
tion (Progenesis)).
(XLSX)
S3 Data Set. Bacterial proteins detected by mass spectrometry (spectral counting (Scaf-
fold)).
(XLSX)
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